Earnings Call · Q2 FY2023·2023-07-27

Q2 23EPS +3.56%·Rev n/aQ1 23EPS -1.20%·Rev n/aQ4 22EPS +0.56%·Rev n/aQ3 22EPS +2.52%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Rick Gonzalez — Chairman of the Board and Chief Executive Officer

Rob Michael — President and Chief Operating Officer

Jeff Stewart — Executive Vice President and Chief Commercial Officer

Carrie Strom — Senior Vice President, AbbVie and President, Global Allergan Aesthetics

Tom Hudson — Senior Vice President, R&D and Chief Scientific Officer

Scott Reents — Executive Vice President

+4.9%1d on move date+5.6% vs SPY3d+5.4%5d+5.3%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access